Earnings call Johnson & Johnson delivered Q1 2026 operational sales growth of 6.4% (7.4% in Innovative Medicine, 4.6% in MedTech), beating consensus and raising full-year guidance. Excluding STELARA, ...
Meagan Flynn covers D.C. government and politics on The Post's Metro team. She started at The Post in 2018 as a nocturnal reporter covering national stories before joining the local desk in 2020 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results